In this week’s episode of Tech Can’t Save Us, hosts Paul David and Maya Dharampal-Hornby are joined by Kevin Flyangolts, Founder & CEO of Aclid. 

With biotechnology becoming increasingly digital and automated, biosecurity guidelines are constantly changing. Aclid enables end-to-end compliance for gene synthesis providers by automating biosecurity screenings, promoting education in the life science sector, and building trust between companies and customers.

Tune into this episode now to hear Kevin discuss how biosecurity concerns have evolved since covid-19, and explain why adaptive regulations, responsible practices, and automated screenings and verifications are the future of biosecurity.

Find more about Aclid here: https://www.aclid.bio/

Get in touch with Kevin here: https://www.linkedin.com/in/kevfly/

Ver todos los episodios